Search clinical trials for: gaboxadol

Total 23 results

Ovid Therapeutics Inc.

Completed

A Study of OV101 in Individuals With Fragile X Syndrome (ROCKET)

Fragile X Syndrome (FXS)

United States
Ovid Therapeutics Inc.

Terminated

An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome (ELARA)

Angelman Syndrome

United States, Israel
H. Lundbeck A/S

Completed

An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)

Insomnia
H. Lundbeck A/S

Completed

Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)

Insomnia
H. Lundbeck A/S

Completed

Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)

Insomnia
H. Lundbeck A/S

Completed

Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)

Primary Insomnia
H. Lundbeck A/S

Withdrawn

An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007)

Insomnia
H. Lundbeck A/S

Completed

Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder

Major Depressive Disorder

Austria, Russian Federation
H. Lundbeck A/S

Completed

MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)

Primary Insomnia
H. Lundbeck A/S

Terminated

Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)

Primary Insomnia
H. Lundbeck A/S

Completed

Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)

Insomnia
H. Lundbeck A/S

Terminated

Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)

Primary Insomnia
Organon and Co

Terminated

Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED)

Asthma
Ovid Therapeutics Inc.

Completed

A Study of OV101 in Individuals With Angelman Syndrome (AS) (NEPTUNE)

Primary Disease or Condition Being Studied: Angelman Syndrome (AS)

United States, Australia, Germany, Israel, Netherlands
H. Lundbeck A/S

Completed

A Study of Gaboxadol in Primary Insomnia

Primary Insomnia
Healx Limited

Withdrawn

Investigation of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) in Male Fragile X Syndrome Patients Aged 13-40 (IMPACT-FXS)

Fragile X Syndrome

United States, Australia
H. Lundbeck A/S

Completed

A Study of Gaboxadol in Primary Insomnia

Primary Insomnia

Sweden
H. Lundbeck A/S

Completed

A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia

Primary Insomnia
H. Lundbeck A/S

Completed

A Study of Gaboxadol in Primary Insomnia

Primary Insomnia

Sweden
Craig Erickson
Healx Limited

Recruiting

Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS)

Fragile X Syndrome

United States
Ovid Therapeutics Inc.

Completed

Single Dose Pharmacokinetic (PK) Study

Fragile X Syndrome | Angelman Syndrome

United States
H. Lundbeck A/S

Completed

A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia

Primary Insomnia

Germany
Ovid Therapeutics Inc.

Completed

A Study in Adults and Adolescents With Angelman Syndrome (STARS)

Angelman Syndrome

United States, Israel

3

Subscribe